DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia Contract Manufacturing Organizations Market, By Type (Active Pharmaceutical Ingredients (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing, Secondary Packaging), By End User, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering.
Saudi Arabia contract manufacturing organizations market is expected to witness growth at a steady rate in the forecast period, 2023-2027. The market growth is driven by the rise in investments in the development of the pharmaceutical industry and drug development processes.
The Saudi Arabia contract manufacturing organizations market is segmented on the basis of type, end user, competitive landscape, and regional distribution. Based on type, the market is fragmented into active pharmaceutical ingredients (API) manufacturing, finished dosage formulation (FDF) development & manufacturing, and secondary packaging.
The active pharmaceutical (API) manufacturing segment is expected to capture the highest market share in the forecast period. The growing demand for pharmaceutical ingredients (API) in the pharmaceutical product designing & manufacturing to increase drug effectiveness is driving the segment growth.
Key Target Audience:
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, Saudi Arabia contract manufacturing organizations market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Saudi Arabia Contract Manufacturing Organizations Market, By Type:
- Active Pharmaceutical Ingredients (API) Manufacturing
- Finished Dosage Formulation (FDF) Development & Manufacturing
- Secondary Packaging
Saudi Arabia Contract Manufacturing Organizations Market, By End User:
- Big Pharmaceuticals
- Small and Mid-Size Pharmaceuticals
- Generic Pharmaceutical Companies
- Others
Saudi Arabia Contract Manufacturing Organizations Market, By Region:
- Western region
- Eastern region
- Northern & Central region
- Southern Region
Key Topics Covered:
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Saudi Arabia Contract Manufacturing Organizations Market
4. Voice of Customer
5. Executive Summary
6. Saudi Arabia Contract Manufacturing Organizations Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Active Pharmaceutical Ingredients (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing, Secondary Packaging)
6.2.2. By End User (Big Pharmaceuticals, Small and Mid-Size Pharmaceuticals, Generic Pharmaceutical Companies, Others)
6.2.3. By Company (2021)
6.2.4. By Region
6.3. Product Market Map
7. Saudi Arabia Active Pharmaceutical Ingredients (API) Manufacturing Organizations Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By End User
8. Saudi Arabia Finished Dosage Formulation (FDF) Development & Manufacturing Organizations Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By End User
9. Saudi Arabia Finished Secondary Packaging Manufacturing Organizations Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
12. Policy & Regulatory Landscape
13. Saudi Arabia Economic Profile
14. Competitive Landscape
15. Strategic Recommendations
Companies Mentioned
- Saudi Arabian-Japanese Pharmaceutical Company (SAJAPHCO)
- AJA Pharmaceutical Industries Company LTD
- Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)
- Jamjoom Pharmaceuticals Co.
- Banjara Holdings
- Batterjee Pharmaceutical
For more information about this report visit https://www.researchandmarkets.com/r/np8dgq
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900